Bioventus (BVS) Depreciation & Amortization (IS) (2020 - 2026)

Bioventus has reported Depreciation & Amortization (IS) for 7 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (IS) fell 30.51% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 30.03% YoY), and the FY2025 full-year result was $5.7 million, down 25.16% from the prior year.
• Depreciation & Amortization (IS) for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
• The five-year high for Depreciation & Amortization (IS) was $3.3 million in Q2 2022, with the low at $1.1 million in Q1 2026.
• Historically, Depreciation & Amortization (IS) has averaged $1.9 million across 5 years, with a median of $2.1 million in 2024.
• The largest YoY upside for Depreciation & Amortization (IS) was 69.04% in 2022 against a maximum downside of 43.02% in 2022.
• Bioventus' Depreciation & Amortization (IS) stood at $1.5 million in 2022, then surged by 36.23% to $2.1 million in 2023, then dropped by 15.89% to $1.8 million in 2024, then declined by 26.64% to $1.3 million in 2025, then fell by 14.65% to $1.1 million in 2026.
• The last three Depreciation & Amortization (IS) figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.